187 related articles for article (PubMed ID: 33055078)
1. Efficacy of tocilizumab in patients with hand osteoarthritis: double blind, randomised, placebo-controlled, multicentre trial.
Richette P; Latourte A; Sellam J; Wendling D; Piperno M; Goupille P; Pers YM; Eymard F; Ottaviani S; Ornetti P; Flipo RM; Fautrel B; Peyr O; Bertola JP; Vicaut E; Chevalier X
Ann Rheum Dis; 2021 Mar; 80(3):349-355. PubMed ID: 33055078
[TBL] [Abstract][Full Text] [Related]
2. Adalimumab in patients with hand osteoarthritis refractory to analgesics and NSAIDs: a randomised, multicentre, double-blind, placebo-controlled trial.
Chevalier X; Ravaud P; Maheu E; Baron G; Rialland A; Vergnaud P; Roux C; Maugars Y; Mulleman D; Lukas C; Wendling D; Lafforgue P; Loeuille D; Foltz V; Richette P;
Ann Rheum Dis; 2015 Sep; 74(9):1697-705. PubMed ID: 24817417
[TBL] [Abstract][Full Text] [Related]
3. Results of a 6-week treatment with 10 mg prednisolone in patients with hand osteoarthritis (HOPE): a double-blind, randomised, placebo-controlled trial.
Kroon FPB; Kortekaas MC; Boonen A; Böhringer S; Reijnierse M; Rosendaal FR; Riyazi N; Starmans M; Turkstra F; van Zeben J; Allaart CF; Kloppenburg M
Lancet; 2019 Nov; 394(10213):1993-2001. PubMed ID: 31727410
[TBL] [Abstract][Full Text] [Related]
4. Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial.
Khanna D; Lin CJF; Furst DE; Goldin J; Kim G; Kuwana M; Allanore Y; Matucci-Cerinic M; Distler O; Shima Y; van Laar JM; Spotswood H; Wagner B; Siegel J; Jahreis A; Denton CP;
Lancet Respir Med; 2020 Oct; 8(10):963-974. PubMed ID: 32866440
[TBL] [Abstract][Full Text] [Related]
5. Early rheumatoid arthritis treated with tocilizumab, methotrexate, or their combination (U-Act-Early): a multicentre, randomised, double-blind, double-dummy, strategy trial.
Bijlsma JWJ; Welsing PMJ; Woodworth TG; Middelink LM; Pethö-Schramm A; Bernasconi C; Borm MEA; Wortel CH; Ter Borg EJ; Jahangier ZN; van der Laan WH; Bruyn GAW; Baudoin P; Wijngaarden S; Vos PAJM; Bos R; Starmans MJF; Griep EN; Griep-Wentink JRM; Allaart CF; Heurkens AHM; Teitsma XM; Tekstra J; Marijnissen ACA; Lafeber FPJ; Jacobs JWG
Lancet; 2016 Jul; 388(10042):343-355. PubMed ID: 27287832
[TBL] [Abstract][Full Text] [Related]
6. A randomised double-blind placebo-controlled crossover trial of HUMira (adalimumab) for erosive hand OsteoaRthritis - the HUMOR trial.
Aitken D; Laslett LL; Pan F; Haugen IK; Otahal P; Bellamy N; Bird P; Jones G
Osteoarthritis Cartilage; 2018 Jul; 26(7):880-887. PubMed ID: 29499287
[TBL] [Abstract][Full Text] [Related]
7. A randomized, double-blind, placebo-controlled trial of low-dose oral prednisolone for treating painful hand osteoarthritis.
Wenham CY; Hensor EM; Grainger AJ; Hodgson R; Balamoody S; Doré CJ; Emery P; Conaghan PG
Rheumatology (Oxford); 2012 Dec; 51(12):2286-94. PubMed ID: 22956551
[TBL] [Abstract][Full Text] [Related]
8. Methotrexate to treat hand osteoarthritis with synovitis (METHODS): an Australian, multisite, parallel-group, double-blind, randomised, placebo-controlled trial.
Wang Y; Jones G; Keen HI; Hill CL; Wluka AE; Kasza J; Teichtahl AJ; Antony B; O'Sullivan R; Cicuttini FM
Lancet; 2023 Nov; 402(10414):1764-1772. PubMed ID: 37839420
[TBL] [Abstract][Full Text] [Related]
9. Etanercept in patients with inflammatory hand osteoarthritis (EHOA): a multicentre, randomised, double-blind, placebo-controlled trial.
Kloppenburg M; Ramonda R; Bobacz K; Kwok WY; Elewaut D; Huizinga TWJ; Kroon FPB; Punzi L; Smolen JS; Vander Cruyssen B; Wolterbeek R; Verbruggen G; Wittoek R
Ann Rheum Dis; 2018 Dec; 77(12):1757-1764. PubMed ID: 30282670
[TBL] [Abstract][Full Text] [Related]
10. Colchicine twice a day for hand osteoarthritis (COLOR): a double-blind, randomised, placebo-controlled trial.
Døssing A; Henriksen M; Ellegaard K; Nielsen SM; Stamp LK; Müller FC; Kloppenburg M; Haugen IK; McCarthy GM; Conaghan PG; Ulff-Møller Dahl L; Terslev L; Altman RD; Becce F; Ginnerup-Nielsen E; Jensen L; Boesen M; Christensen R; Dal U; Bliddal H
Lancet Rheumatol; 2023 May; 5(5):e254-e262. PubMed ID: 38251589
[TBL] [Abstract][Full Text] [Related]
11. Tocilizumab for induction and maintenance of remission in giant cell arteritis: a phase 2, randomised, double-blind, placebo-controlled trial.
Villiger PM; Adler S; Kuchen S; Wermelinger F; Dan D; Fiege V; Bütikofer L; Seitz M; Reichenbach S
Lancet; 2016 May; 387(10031):1921-7. PubMed ID: 26952547
[TBL] [Abstract][Full Text] [Related]
12. Early effects of tocilizumab in the treatment of moderate to severe active rheumatoid arthritis: a one-week sub-study of a randomised controlled trial (Rapid Onset and Systemic Efficacy [ROSE] Study).
Yazici Y; Curtis JR; Ince A; Baraf HS; Lepley DM; Devenport JN; Kavanaugh A
Clin Exp Rheumatol; 2013; 31(3):358-64. PubMed ID: 23305631
[TBL] [Abstract][Full Text] [Related]
13. Tocilizumab in patients with adult-onset still's disease refractory to glucocorticoid treatment: a randomised, double-blind, placebo-controlled phase III trial.
Kaneko Y; Kameda H; Ikeda K; Ishii T; Murakami K; Takamatsu H; Tanaka Y; Abe T; Takeuchi T
Ann Rheum Dis; 2018 Dec; 77(12):1720-1729. PubMed ID: 30279267
[TBL] [Abstract][Full Text] [Related]
14. Teprotumumab for patients with active thyroid eye disease: a pooled data analysis, subgroup analyses, and off-treatment follow-up results from two randomised, double-masked, placebo-controlled, multicentre trials.
Kahaly GJ; Douglas RS; Holt RJ; Sile S; Smith TJ
Lancet Diabetes Endocrinol; 2021 Jun; 9(6):360-372. PubMed ID: 33865501
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of tanezumab added on to diclofenac sustained release in patients with knee or hip osteoarthritis: a double-blind, placebo-controlled, parallel-group, multicentre phase III randomised clinical trial.
Balanescu AR; Feist E; Wolfram G; Davignon I; Smith MD; Brown MT; West CR
Ann Rheum Dis; 2014 Sep; 73(9):1665-72. PubMed ID: 23852695
[TBL] [Abstract][Full Text] [Related]
16. Correlation of pain relief with physical function in hand osteoarthritis: randomized controlled trial post hoc analysis.
Barthel HR; Peniston JH; Clark MB; Gold MS; Altman RD
Arthritis Res Ther; 2010; 12(1):R7. PubMed ID: 20064249
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of tocilizumab in patients with refractory Takayasu arteritis: results from a randomised, double-blind, placebo-controlled, phase 3 trial in Japan (the TAKT study).
Nakaoka Y; Isobe M; Takei S; Tanaka Y; Ishii T; Yokota S; Nomura A; Yoshida S; Nishimoto N
Ann Rheum Dis; 2018 Mar; 77(3):348-354. PubMed ID: 29191819
[TBL] [Abstract][Full Text] [Related]
18. A prospective, randomised, double blind placebo-controlled trial to evaluate the efficacy and safety of tocilizumab in patients with severe COVID-19 pneumonia (TOC-COVID): A structured summary of a study protocol for a randomised controlled trial.
Rilinger J; Kern WV; Duerschmied D; Supady A; Bode C; Staudacher DL; Wengenmayer T
Trials; 2020 Jun; 21(1):470. PubMed ID: 32493514
[TBL] [Abstract][Full Text] [Related]
19. Symptomatic effects of chondroitin 4 and chondroitin 6 sulfate on hand osteoarthritis: a randomized, double-blind, placebo-controlled clinical trial at a single center.
Gabay C; Medinger-Sadowski C; Gascon D; Kolo F; Finckh A
Arthritis Rheum; 2011 Nov; 63(11):3383-91. PubMed ID: 21898340
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of a supplement combination on hand pain among people with symptomatic hand osteoarthritis an internet-based, randomised clinical trial the RADIANT study.
Liu X; Robbins S; Eyles J; Fedorova T; Virk S; Deveza LA; McLachlan AJ; Hunter DJ
Osteoarthritis Cartilage; 2021 May; 29(5):667-677. PubMed ID: 33617972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
